Two months ago, the medical community was all abuzz over a big clinical study that showed a prescription fish-oil supplement could reduce the risk of heart disease. Today, a fuller look at the data presents a more nuanced picture.
Doctors working on the REDUCE-IT trial, which enrolled more than 8,000 people, published the full set of data today in the New England Journal of Medicine (NEJM) and presented it at the American Heart Association conference in Chicago. The big takeaway, which caused cardiologists to do a double-take in September, remains unchanged. The prescription-grade pill, branded Vascepa, reduced the risk of… Read more »
UNDERWRITERS AND PARTNERS